Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 17 Mar 2023
Germany: Activation of bitter taste receptors opens lung pathways, making them potential targets for the treatment of chronic lung diseases...
Read Full NewsPain that interferes with daily functioning is associated with higher odds of frailty and its progression in adult survivors of childhood cancer.
Cancer care is becoming too complex for any one clinician to track alone, making AI an increasingly valuable tool in modern oncology.
New data with longer-term follow-up suggest that PSA screening probably lowers prostate cancer mortality — but experts stress the gains are modest and come with risk for overdiagnosis.
The CAPItello-281 trial reported a 19% improvement in radiographic progression-free survival.
1.
How to keep your prostate healthy and lower your risk of developing serious problems
2.
Video: How to treat kidney disease?
3.
Gene Therapy for Rare Brain Disease Effective, but Comes With Blood Cancer Risk
4.
Childhood cancer survivors face new health problems later in life, study shows
5.
For the first time in humans, a chemotherapy drug reaches the brain.
1.
The Predictive Power of Theranostics in Palliative Neuroendocrine Tumor Management
2.
Clinical Analysis of Prostate Cancer
3.
Transformative Frameworks in Oncology for Better Care
4.
The Benefits and Side Effects of Bortezomib in the Fight Against Cancer
5.
Innovative Solutions in Hematology for Specialists
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
Evolution in Treatment and Diagnosis of Lung Cancer- An Initiative from Manipal Hospitals
2.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III
3.
Current Scenario of Cancer- Q&A Session to Close the Gap Part II
4.
Navigating the Complexities of Ph Negative ALL - Part I
5.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge